BI-2 destabilizes HIV-1 cores during infection and Prevents Binding of CPSF6 to the HIV-1 Capsid

被引:44
|
作者
Fricke, Thomas [1 ]
Buffone, Cindy [1 ]
Opp, Silvana [1 ]
Valle-Casuso, Jose [1 ]
Diaz-Griffero, Felipe [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, New York, NY 10461 USA
来源
RETROVIROLOGY | 2014年 / 11卷
基金
美国国家卫生研究院;
关键词
HIV-1; BI-2; PF74; Capsid; Stability; Uncoating; CPSF6; TRIM5-ALPHA RESTRICTION; RING DOMAIN; REPLICATION; INHIBITION; STABILIZE; ABILITY; CELLS;
D O I
10.1186/s12977-014-0120-x
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: The recently discovered small-molecule BI-2 potently blocks HIV-1 infection. BI-2 binds to the N-terminal domain of HIV-1 capsid. BI-2 utilizes the same capsid pocket used by the small molecule PF74. Although both drugs bind to the same pocket, it has been proposed that BI-2 uses a different mechanism to block HIV-1 infection when compared to PF74. Findings: This work demonstrates that BI-2 destabilizes the HIV-1 core during infection, and prevents the binding of the cellular factor CPSF6 to the HIV-1 core. Conclusions: Overall this short-form paper suggests that BI-2 is using a similar mechanism to the one used by PF74 to block HIV-1 infection.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] The HIV-1 capsid-binding host factor CPSF6 is post-transcriptionally regulated by the cellular microRNA miR-125b
    Chaudhuri, Evan
    Dash, Sabyasachi
    Balasubramaniam, Muthukumar
    Padron, Adrian
    Holland, Joseph
    Sowd, Gregory A.
    Villalta, Fernando
    Engelman, Alan N.
    Pandhare, Jui
    Dash, Chandravanu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (15) : 5081 - 5094
  • [22] Biochemical detection of capsid in the nucleus during HIV-1 infection
    Selyutina, Anastasia
    Diaz-Griffero, Felipe
    STAR PROTOCOLS, 2021, 2 (01):
  • [23] Soluble host factors CPSF6 and CypA determine the HIV-1 nuclear import pathway.
    Xue, G.
    Yu, H.
    Goh, S.
    Gres, A.
    Sarafianos, S.
    Luban, J.
    KewalRamani, V. N.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [24] Shielding the HIV-1 capsid
    Christopher Aiken
    Nature Microbiology, 2020, 5 : 12 - 13
  • [25] Shielding the HIV-1 capsid
    Aiken, Christopher
    NATURE MICROBIOLOGY, 2020, 5 (01) : 12 - 13
  • [26] HIV-1 transmission and acute HIV-1 infection
    Hansasuta, P
    Rowland-Jones, SL
    BRITISH MEDICAL BULLETIN, 2001, 58 : 109 - 127
  • [27] HIV-1 SPECIFIC CTL DURING THE CLINICAL COURSE OF HIV-1 INFECTION
    MIEDEMA, F
    VANBAALEN, CA
    HOLWERDA, AM
    KERKHOFGARDE, SR
    KEET, IPM
    SCHATTENKERK, JKME
    KLEIN, MR
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 223 - 223
  • [28] A critical role for alternative polyadenylation factor CPSF6 in targeting HIV-1 integration to transcriptionally active chromatin
    Sowd, Gregory A.
    Serrao, Erik
    Wang, Hao
    Wang, Weifeng
    Fadel, Hind J.
    Poeschla, Eric M.
    Engelman, Alan N.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (08) : E1054 - E1063
  • [29] A Carboxy-Terminally Truncated Human CPSF6 Lacking Residues Encoded by Exon 6 Inhibits HIV-1 cDNA Synthesis and Promotes Capsid Disassembly
    Hori, Takanori
    Takeuchi, Hiroaki
    Saito, Hideki
    Sakuma, Ryuta
    Inagaki, Yoshio
    Yamaoka, Shoji
    JOURNAL OF VIROLOGY, 2013, 87 (13) : 7726 - 7736
  • [30] Mixed cryoglobulinemia in HIV-1 infection: The role of HIV-1
    Dimitrakopoulos, AN
    Kordossis, T
    Hatzakis, A
    Moutsopoulos, HM
    ANNALS OF INTERNAL MEDICINE, 1999, 130 (03) : 226 - 230